Perspective  	Perspective  	 NNP	O
of  	of  	 IN	O
vaccine  	vaccine  	 NN	B-NP
manufacturers  	manufacturers  	 NNS	I-NP
on  	on  	 IN	O
financing  	financing  	 VBG	O
pediatric  	pediatric  	 JJ	O
and  	and  	 CC	O
adolescent  	adolescent  	 JJ	O
vaccines  	vaccines  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
The  	The  	 DT	O
goal  	goal  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
understand  	understand  	 VB	O
vaccine  	vaccine  	 NN	B-NP
manufacturers 	manufacturers 	 NNS	I-NP
'  	'  	 POS	O
perspectives  	perspectives  	 NN	B-NP
on  	on  	 IN	O
vaccine  	vaccine  	 NN	B-NP
financing  	financing  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
barrier  	barrier  	 NN	O
to  	to  	 TO	O
immunization 	immunization 	 VB	B-NP
.  	.  	 .	O
Individual  	Individual  	 JJ	B-NP
telephone  	telephone  	 NN	I-NP
interviews  	interviews  	 NNS	I-NP
with  	with  	 IN	O
representatives  	representatives  	 NNS	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
6  	6  	 CD	O
manufacturers  	manufacturers  	 NNS	B-NP
that  	that  	 WDT	O
produce  	produce  	 VBP	O
routinely  	routinely  	 RB	O
recommended  	recommended  	 VBN	B-NP
vaccines  	vaccines  	 NNS	I-NP
for  	for  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
were  	were  	 VBD	O
conducted  	conducted  	 VBN	O
in  	in  	 IN	O
November  	November  	 NNP	O
and  	and  	 CC	O
December  	December  	 NNP	O
2006 	2006 	 CD	O
.  	.  	 .	O
Although  	Although  	 IN	O
manufacturers  	manufacturers  	 NNS	B-NP
acknowledged  	acknowledged  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
price  	price  	 NN	O
of  	of  	 IN	O
newer  	newer  	 JJR	O
vaccines  	vaccines  	 NN	O
presents  	presents  	 VBZ	O
challenges  	challenges  	 NNS	O
to  	to  	 TO	O
optimal  	optimal  	 VB	B-NP
vaccine  	vaccine  	 NN	I-NP
use 	use 	 NN	I-NP
,  	,  	 ,	O
they  	they  	 PRP	O
asserted  	asserted  	 VBD	O
that  	that  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 NNS	O
have  	have  	 VBP	O
access  	access  	 NN	O
to  	to  	 TO	O
vaccinations  	vaccinations  	 VB	B-NP
through  	through  	 IN	O
public  	public  	 JJ	O
and  	and  	 CC	O
private  	private  	 JJ	O
insurance 	insurance 	 NN	O
.  	.  	 .	O
Respondents  	Respondents  	 NNS	O
suggested  	suggested  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
system  	system  	 NN	O
could  	could  	 MD	O
be  	be  	 VB	O
improved  	improved  	 VBN	O
through  	through  	 IN	O
adequate  	adequate  	 JJ	O
funding  	funding  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
public-sector  	public-sector  	 JJ	B-NP
safety  	safety  	 NN	I-NP
net 	net 	 NN	I-NP
.  	.  	 .	O
Respondents  	Respondents  	 NNS	O
stated  	stated  	 VBN	O
that  	that  	 IN	O
providers  	providers  	 NNS	O
should  	should  	 MD	O
receive  	receive  	 VB	O
timely  	timely  	 JJ	O
reimbursement  	reimbursement  	 NN	B-NP
for  	for  	 IN	O
the  	the  	 DT	O
full  	full  	 JJ	O
costs  	costs  	 NNS	O
of  	of  	 IN	O
vaccine  	vaccine  	 NN	B-NP
purchase  	purchase  	 NN	I-NP
and  	and  	 CC	O
administration 	administration 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
manufacturers  	manufacturers  	 NNS	B-NP
who  	who  	 WP	O
sell  	sell  	 VBP	O
directly  	directly  	 RB	O
to  	to  	 TO	O
health  	health  	 NN	B-NP
care  	care  	 NN	I-NP
providers  	providers  	 NNS	I-NP
may  	may  	 MD	O
provide  	provide  	 VB	O
flexible  	flexible  	 JJ	O
payment  	payment  	 NN	B-NP
terms  	terms  	 NNS	I-NP
for  	for  	 IN	I-NP
vaccine  	vaccine  	 NN	I-NP
purchases 	purchases 	 NNS	I-NP
.  	.  	 .	O
Manufacturers  	Manufacturers  	 NNS	B-NP
supported  	supported  	 VBD	O
targeted  	targeted  	 VBN	B-NP
expansion  	expansion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
Vaccines  	Vaccines  	 NNP	O
for  	for  	 IN	O
Children  	Children  	 NNP	B-NP
program  	program  	 NN	I-NP
to  	to  	 TO	O
allow  	allow  	 VB	O
children  	children  	 NNS	O
with  	with  	 IN	O
incomplete  	incomplete  	 JJ	O
insurance  	insurance  	 NN	B-NP
coverage  	coverage  	 NN	I-NP
for  	for  	 IN	O
vaccines  	vaccines  	 NNS	O
to  	to  	 TO	O
receive  	receive  	 VB	O
vaccines  	vaccines  	 NNS	O
at  	at  	 IN	O
health  	health  	 NN	B-NP
department  	department  	 NN	I-NP
clinics 	clinics 	 NNS	I-NP
.  	.  	 .	O
Manufacturers  	Manufacturers  	 NNS	B-NP
perceived  	perceived  	 VBN	I-NP
delays  	delays  	 NNS	I-NP
in  	in  	 IN	O
publication  	publication  	 NN	O
of  	of  	 IN	O
Advisory  	Advisory  	 NNP	B-NP
Committee  	Committee  	 NNP	I-NP
on  	on  	 IN	O
Immunization  	Immunization  	 NNP	B-NP
Practices  	Practices  	 NNPS	I-NP
recommendations  	recommendations  	 NNS	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
barrier  	barrier  	 NN	I-NP
to  	to  	 TO	O
vaccine  	vaccine  	 NN	B-NP
uptake 	uptake 	 NN	I-NP
.  	.  	 .	O
They  	They  	 PRP	O
viewed  	viewed  	 VBD	O
the  	the  	 DT	O
perceived  	perceived  	 JJ	O
lack  	lack  	 NN	O
of  	of  	 IN	O
public  	public  	 JJ	B-NP
value  	value  	 NN	I-NP
for  	for  	 IN	O
vaccines  	vaccines  	 NNS	O
as  	as  	 IN	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
barrier  	barrier  	 NN	I-NP
to  	to  	 TO	O
adequate  	adequate  	 JJ	O
reimbursement  	reimbursement  	 NN	B-NP
and  	and  	 CC	O
optimal  	optimal  	 JJ	B-NP
utilization 	utilization 	 NN	I-NP
.  	.  	 .	O
Respondents  	Respondents  	 NNS	O
also  	also  	 RB	O
maintained  	maintained  	 VBN	O
that  	that  	 IN	O
their  	their  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
negotiate  	negotiate  	 VB	O
vaccine  	vaccine  	 NN	B-NP
prices  	prices  	 NNS	I-NP
through  	through  	 IN	O
the  	the  	 DT	O
private  	private  	 JJ	O
market  	market  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
crucial  	crucial  	 JJ	O
priority 	priority 	 NN	O
.  	.  	 .	O
Manufacturers  	Manufacturers  	 NNS	B-NP
assert  	assert  	 VBP	O
that  	that  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 NNS	O
have  	have  	 VBP	O
access  	access  	 NN	O
to  	to  	 TO	O
immunizations  	immunizations  	 VB	B-NP
through  	through  	 IN	O
public  	public  	 JJ	O
and  	and  	 CC	O
private  	private  	 JJ	O
insurance 	insurance 	 NN	O
.  	.  	 .	O
Manufacturers  	Manufacturers  	 NNS	B-NP
think  	think  	 VBP	O
that  	that  	 IN	O
they  	they  	 PRP	O
have  	have  	 VBP	O
mitigated  	mitigated  	 VBG	O
the  	the  	 DT	O
challenge  	challenge  	 NN	O
most  	most  	 RBS	O
directly  	directly  	 RB	O
in  	in  	 IN	O
their  	their  	 PRP$	O
control 	control 	 NN	O
:  	:  	 :	O
the  	the  	 DT	O
large  	large  	 JJ	O
financial  	financial  	 JJ	B-NP
outlays  	outlays  	 NNS	I-NP
required  	required  	 VBN	O
for  	for  	 IN	O
up-front  	up-front  	 JJ	B-NP
vaccine  	vaccine  	 NN	I-NP
purchases 	purchases 	 NNS	I-NP
.  	.  	 .	O
